(Q51564959)

7 April 2018

title

Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients. (English)

1 reference

7 April 2018

9

Castro GR

1 reference

7 April 2018

Brites FD

1

1 reference

7 April 2018

Cavallero E

2

1 reference

7 April 2018

de Geitere C

3

1 reference

7 April 2018

Nicolaïew N

4

1 reference

7 April 2018

Jacotot B

5

1 reference

7 April 2018

Rosseneu M

6

1 reference

7 April 2018

Fruchart JC

7

1 reference

7 April 2018

Wikinski RL

8

1 reference

7 April 2018

publication date

1 January 1999

1 reference

7 April 2018

published in

Clinica Chimica Acta

1 reference

7 April 2018

volume

279

1 reference

7 April 2018

issue

1-2

1 reference

7 April 2018

page(s)

1-14

1 reference

7 April 2018

Postprandial amplification of lipoprotein abnormalities in controlled type II diabetic subjects: relationship to postprandial lipemia and C-peptide/glucagon levels.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

Effects of high-density lipoprotein particles containing apo A-I, with or without apo A-II, on intracellular cholesterol efflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

Evidence for a lipoprotein carrier in human plasma catalyzing sterol efflux from cultured fibroblasts and its relationship to lecithin:cholesterol acyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

The role of apolipoprotein A-I-containing lipoproteins in atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

Effects of postprandial lipemia on plasma cholesterol metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

Lipoprotein disorders in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2898%2900155-7

10.1016/S0009-8981(98)00155-7

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018